Type of cancer | Specific markers | References |
---|---|---|
AML | CD34+CD38-Lin- | [10] |
AML | CD123+ | |
AML | CD47+ | [14] |
Breast cancer | CD24-CD44+Lin- | |
Breast cancer | ALDH1+ | |
Brain tumors | CD133+ | |
Glioblastoma | SSEA-1+ | [21] |
Glioblastoma | A2B5+ | [22] |
Prostate cancer | a2β1hiCD133+ | [23] |
Prostate cancer | Lin-Sca-1+CD49fhigh | [24] |
Bladder cancer | ALDH1+ | [25] |
Lung cancer | SP-C+CCA+ | [26] |
Lung cancer | CD133+ | [27] |
Lung cancer | ALDH1+ | [28] |
Melanoma | CD20+MCAM+ | [29] |
Melanoma | CD133+ABCG2+ | [30] |
Melanoma | MDR1+ | [31] |
Melanoma | ABCG5+ | [32] |
Melanoma | CD271+ | [33] |
Melanoma | JARID1B+ | [34] |
Colon cancer | CD133+ | |
Colon cancer | Lgr5+ | [39] |
Colon cancer | ALDH1+ | [40] |
Colorectal cancer | CD44+ESAhiCD166+ | [41] |
Colorectal cancer | CD26+ | [42] |
Intestinal cancer | Lgr5+ | [39] |
Intestinal cancer | CD133+ | [43] |
Pancreatic cancer | CD44+CD24+ESA+ | [44] |
Pancreatic cancer | CD133+ | [45] |
HNSCC | CD44+ | [46] |
HNSCC | ALDH1+ | [47] |
B-precursor ALL | CD34+CD38+ CD19+; CD34+CD38-CD19+ | [48] |
Ovarian cancer | CD44+CD117+ | [49] |
Ovarian cancer | CD133+ | [50] |
Endometrial tumors | CD133+ | [51] |
Liver cancer | CD90+ | [52] |
Liver cancer | CD133+ | [53] |
Liver cancer | EpCAM+ | [54] |
Renal carcinomas | CD105+ | [55] |
Medulloblastoma | CD15+ | |
Gastric cancer | CD44+ | [58] |
Osteosarcoma | Oct-4+ | [59] |